News Releases - DICE Therapeutics

Skip to main navigation

Careers Contact Search

About

Overview Leadership Board

Science

Pipeline

Overview IL-17 Integrin Programs

Investors

Overview News Releases Events and Presentations

Events Presentations

Corporate Governance

Governance Overview Committee Composition

Financial Information

SEC Filings

Stock Information

Stock Quote & Chart

Shareholder Services

Investor FAQs Email Alerts RSS Feeds

Investors

News Releases

Year

Nov 16, 2021

DICE Therapeutics to Present at November Investor Conferences

Nov 12, 2021

DICE Therapeutics Reports Third Quarter 2021 Financial Results and Recent Highlights

Oct 25, 2021

DICE Therapeutics Initiates Phase 1 Clinical Trial of S011806 for the Treatment of Psoriasis

Sep 14, 2021

DICE Therapeutics Announces Pricing of Upsized Initial Public Offering

Quick Links

SEC Filings
RSS Feeds
Investor FAQs

Contact Us

Investors

investors@dicetx.com

Investor Email Alerts

Request Email Alerts

DICE Therapeutics ©

2021